202
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database

, , , &
Pages 409-421 | Published online: 22 Jul 2015

Figures & data

Figure 1 Patient identification flow chart.

Figure 1 Patient identification flow chart.

Table 1 Baseline patient demographics and admitting hospital characteristics

Table 2 Hospital characteristics

Figure 2 Percentage of patients with a major bleeding event despite hemostat use, stratified by surgery group.

Notes: Major bleeding (ie, uncontrolled bleeding) events were defined as: hemorrhage or hematoma complicating a procedure; interventions to control bleeding; charges billed for use of hemovac drainage devices; charges billed for use of erythropoietin; blood product transfusions; and charges billed for cryoprecipitates, fresh frozen plasma, red blood cells, plasma, platelets, and whole blood.
Figure 2 Percentage of patients with a major bleeding event despite hemostat use, stratified by surgery group.

Figure 3 Patient mortality, stratified by surgery type and presence or absence of uncontrolled bleeding despite hemostat use.

Note: *Statistically significant (P<0.001).
Figure 3 Patient mortality, stratified by surgery type and presence or absence of uncontrolled bleeding despite hemostat use.

Table 3 Unadjusted mean (SD) costs and resource use, stratified by surgical procedure and presence or absence of uncontrolled bleeding despite hemostat use

Table 4 Mean adjusted all-cause costs (95% CI) and mean adjusted hospital LOS (95% CI) for controlled versus uncontrolled bleeding in patients treated with hemostatic agents, stratified by surgical procedure

Table S1 Selected primary surgical procedures

Table S2 Hemostatic agents

Table S3 Major bleeding events

Table S4 Infections

Table S5 Transfusion coding descriptions